Akers Bio logo
Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line
December 08, 2017 10:31 ET | Akers Biosciences Inc
THOROFARE, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Bio logo
Akers Biosciences Announces Q3 2017 Earnings
November 15, 2017 07:00 ET | Akers Biosciences Inc
 Revenues up 10% as Breathalyzers and Cholesterol Tests Begin to Contribute THOROFARE, N.J, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L),...
Akers Bio logo
Akers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer
November 14, 2017 07:00 ET | Akers Biosciences Inc
Distributor Accutest Now Selling Through Today’s Group THOROFARE, N.J, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a...
Akers Bio logo
Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration
November 04, 2015 07:00 ET | Akers Biosciences Inc.
THOROFARE, N.J., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of healthcare...